Helius Medical Technologies Inc (OTCMKTS:HSDT) CFO Joyce N. Laviscount acquired 79,082 shares of the business’s stock in a transaction dated Friday, December 22nd. The shares were acquired at an average price of $1.96 per share, for a total transaction of $155,000.72. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website.
Shares of Helius Medical Technologies Inc (OTCMKTS:HSDT) traded down $0.01 during trading on Friday, hitting $2.25. The stock had a trading volume of 820 shares, compared to its average volume of 37,162. Helius Medical Technologies Inc has a one year low of $1.29 and a one year high of $4.14. The company has a market cap of $273.04, a PE ratio of -5.49 and a beta of 1.59.
Separately, ValuEngine cut Helius Medical Technologies from a “hold” rating to a “sell” rating in a research note on Friday, December 1st.
ILLEGAL ACTIVITY WARNING: This piece of content was originally published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://ledgergazette.com/2018/01/12/joyce-n-laviscount-purchases-79082-shares-of-helius-medical-technologies-inc-hsdt-stock.html.
About Helius Medical Technologies
Helius Medical Technologies, Inc is a medical technology company focused on neurological wellness. The Company focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company is engaged in the development of its product, the portable neuromodulation stimulator (PoNS) device.
Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.